Zhonggu Logistics plans to sell three container ships, "Zhonggu 20", "Zhonggu 21", and "Zhonggu Chengdu", through public auction or private transfer. The estimated total sale price is no less than 570 million yuan. This move aims to optimize the fleet's structure and increase the proportion of energy-efficient vessels. Separately, Huadong Medicine's subsidiary received approval for a clinical trial for an ADC drug targeting ROR1 for classic Hodgkin lymphoma, which is expected to enhance the company's competitiveness in oncology. AI
RANK_REASON The cluster contains a mix of business news (ship sale) and a clinical trial approval, neither of which are frontier releases or significant industry-wide events.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
